AlexandraDrakakiMD
Oncology • Santa Monica, CAGenitourinary Oncology, Hematologic Oncology
Clinical Instructor, UCLA
Dr. Drakaki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2020 Santa Monica Blvd., Suite 600
Santa Monica, CA 90404Phone+1 310-829-5471Fax+1 310-829-5471- Is this information wrong?
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
Tufts Medical CenterResidency, Internal Medicine, 2007 - 2010
University of Crete School of Health SciencesClass of 2006
Certifications & Licensure
CA State Medical License 2013 - 2025
MA State Medical License Active through 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- FELLOWSHIP/ GI ASCO MERITT AWARD ASCO, 2013
Clinical Trials
- A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer Start of enrollment: 2015 Jul 13
Publications & Presentations
PubMed
- Gain of Chromosome 5q Predicts a Favorable Prognosis in Localized Renal Cell Carcinoma.Cedric Lebacle, Aydin Pooli, Brian Shuch, Nagesh Rao, Karim Chamie, Nils Kroeger, Izak Faiena, Sandy Liu, Erika L Wood, Arie Belldegrun, Alexandra Drakaki, Allan J Pan...> ;Cancer Investigation. 2024 Jan 1
- Effects of novel androgen receptor signaling inhibitors on PSMA PET signal intensity in patients with castrate-resistant prostate cancer: a prospective exploratory ser...Ida Sonni, Lena M Unterrainer, Rejah M Alano, Stephanie Lira, John Shen, Alexandra Drakaki, Tristan Grogan, Matthew B Rettig, Johannes Czernin, Jeremie Calais, Andrei ...> ;EJNMMI Research. 2023 Oct 30
- Associations of quantitative whole-body PSMA-PET metrics with PSA progression status under long-term androgen deprivation therapy in prostate cancer patients: a retros...Vishnu Murthy, Emmanuel Appiah-Kubi, Kathleen Nguyen, Pan Thin, Masatoshi Hotta, John Shen, Alexandra Drakaki, Matthew Rettig, Jeremie Calais, Ida Sonni, Andrei Gafita> ;European Journal of Hybrid Imaging. 2023 Oct 2
- Join now to see all
Authored Content
- Association of Baseline Systemic Corticosteroid Use with Overall Survival and Time to Next Treatment in Patients Receiving Immune Checkpoint Inhibitor Therapy in Real-World US Oncology Practice for Advanced Non-Small Cell Lung Cancer, Melanoma, or Urothelial CarcinomaJune 2020
Press Mentions
Adjuvant Therapy for Improved Disease-Free Survival for Patients with Muscle-Invasive Urothelial Carcinoma Following Radical Surgery - Checkmate 274 - Petros GrivasMarch 28th, 2021
Impact of Early Steroid Initiation During Immune Checkpoint InhibitionJanuary 25th, 2020
For Reasons Unknown, Colon and Rectal Cancer Rates Are Rising in People Under 50November 6th, 2014
Grant Support
- Role of mir9 in liver oncogenesisUCLAPresent
Research History
- PhD/Identification of microRNA signature in liver oncogenesis2015 - Present
Other Languages
- Greek
Hospital Affiliations
UCLA Medical Center-Santa MonicaSanta Monica, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
